These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2097152)

  • 1. Endometrial cancer: our experience.
    di Leo S; Meli MT; Venti EW; Bonaccorsi G; Caschetto S
    Eur J Gynaecol Oncol; 1990; 11(5):361-8. PubMed ID: 2097152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of depth of myometrial invasion in endometrial adenocarcinoma.
    Goff BA; Rice LW
    Gynecol Oncol; 1990 Jul; 38(1):46-8. PubMed ID: 2354826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
    Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
    Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrence of endometrial cancer and its pathological factors].
    Kondo Y; Gorai I; Yanagibashi T; Yanagisawa T; Hirahara F; Ohtsuka T; Kimura A; Uemura T; Minaguchi H; Kikyo S
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1105-9. PubMed ID: 2398296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors.
    Chen SS; Lee L
    Gynecol Oncol; 1983 Dec; 16(3):319-25. PubMed ID: 6654176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma.
    Gal D; Recio FO; Zamurovic D; Tancer ML
    Gynecol Oncol; 1991 Aug; 42(2):142-5. PubMed ID: 1894173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue.
    Oakley G; Nahhas WA
    Eur J Gynaecol Oncol; 1989; 10(4):255-60. PubMed ID: 2776782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
    Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.
    Boronow RC; Morrow CP; Creasman WT; Disaia PJ; Silverberg SG; Miller A; Blessing JA
    Obstet Gynecol; 1984 Jun; 63(6):825-32. PubMed ID: 6728365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
    Ambros RA; Kurman RJ
    Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial carcinoma--stage I. Evaluation of risk and prognostic factors in an analysis of 120 cases].
    Romano FM; Bruno G; Manicastri AM
    Minerva Ginecol; 1991 Mar; 43(3):97-104. PubMed ID: 2057108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
    Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
    Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma IB of the endometrium: spread and prognostic factors.
    Lecca U; Medda F; Parodo G; Puligheddu P; Marcello C
    Eur J Gynaecol Oncol; 1987; 8(2):127-30. PubMed ID: 3569330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis.
    Schink JC; Lurain JR; Wallemark CB; Chmiel JS
    Obstet Gynecol; 1987 Aug; 70(2):216-9. PubMed ID: 3601286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometrial cancer: what's new?].
    Narducci F; Lambaudie E; Sonoda Y; Papageorgiou T; Taïeb S; Cabaret V; Castelain B; Leblanc E; Querleu D
    Gynecol Obstet Fertil; 2003; 31(7-8):581-96. PubMed ID: 14563602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.